1-5 of 5
Kevin M. Gallagher, MD
Close
Sort by
Journal Articles

Comparative Efficacy of First-Line Chemotherapy-Free Combinations in Chronic Lymphocytic Leukemia (CLL): A Network Meta-Analysis

Philip A Haddad, MD, Nowell Ganey, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-136411
Published: 2020
Journal Articles

The Impact of Rituximab on the Clinical Outcomes of Primary Central Nervous System Lymphoma (PCNSL) When Added to Combination Chemotherapy: A Comprehensive Meta-Analysis

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136427
Published: 2020
Journal Articles

The Impact of Chromothripsis on the Clinical Outcomes of Acute Myeloid Leukemia (AML): A Meta-Analysis

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-136404
Published: 2020
Journal Articles

Comparative Efficacy of First-Line Regimens in Relapsed/Refractory Mantle Cell Lymphoma (MCL): A Proportional Meta-Analysis

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-136416
Published: 2020
Journal Articles

Epidemiology and Clinicopathology of Hepatosplenic T-Cell Lymphoma (HSTCL): Analysis of a Pooled Database

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-136463
Published: 2020